Alan Neal Binnick, MD | |
140 Hospital Dr, Suite 109, Bennington, VT 05201-5010 | |
(802) 447-7441 | |
(802) 447-0254 |
Full Name | Alan Neal Binnick |
---|---|
Gender | Male |
Speciality | Dermatology - Dermatopathology |
Location | 140 Hospital Dr, Bennington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699761528 | NPI | - | NPPES |
1075267 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0900X | Dermatology - Dermatopathology | 0420005614 (Vermont) | Primary |
207ND0900X | Dermatology - Dermatopathology | 43419 (Massachusetts) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Alan Neal Binnick, MD 140 Hospital Dr, Suite 109, Bennington, VT 05201-5010 Ph: (802) 447-7441 | Alan Neal Binnick, MD 140 Hospital Dr, Suite 109, Bennington, VT 05201-5010 Ph: (802) 447-7441 |
News Archive
The Monell Center, in partnership with the University of Florida Center for Smell and Taste and the Rocky Mountain Taste and Smell Center at the University of Colorado School of Medicine, will host an interdisciplinary two-day conference in November 2018 to establish a roadmap for treatment-focused research on smell and taste disorders.
With all the talk about health care recently, I'm surprised that no one has challenged the crazy idea that hospitals should treat people who can't pay. This is a free market nation, dammit! The home of "No Shirt, No Shoes, No Dice" in store windows should have "No Cash, No Insurance, No Live" on our hospital doors.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing four new Research Units. The decision was made by the DFG Senate at its December session in Bonn. The establishment of the Research Units will enable researchers to explore prevailing topical questions and generate new approaches in their respective fields.
Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.
Teva Pharmaceutical Industries Ltd. announced today that Teva-KOWA Pharma Co., Ltd., the Company's joint venture in Japan with KOWA Company, Ltd., has signed a definitive agreement to acquire a majority of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.
› Verified 5 days ago
Dr. Lixia Zhao Ellis, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-5544 |